Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Mirum Pharmaceuticals, Inc. MIRM

Set alert

Price alert · MIRM

All alert types
85.74 USD +0.74 +0.87%

At close · Nov 2

85.74 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
85.79 × 2
Ask
85.85 × 2
83.69 Day range 86.52
63.23 52-week range 130.00
YTD
+8.55%
1 year
+18.02%
Open
85.55
Prev close
85.00
Mkt cap
5.57B
Vol
522.77K
Avg vol
723.43K
EPS
-14.24
P/E
0.00
Div yield
0.00%
More statistics
Low
83.69
High
86.52
Forward P/E
-121.62
Beta
0.74
Short ratio
7.16
Inst. own
113.63%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
89.93
200-d avg
98.57
1y target
153.43

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 6, 2025Earnings: -0.12; estimate -0.31; surprise 61.29%
  • Nov 4, 2025Earnings: 0.05; estimate -0.1; surprise 150%
  • Feb 25, 2026Earnings: -0.11; estimate 0.02; surprise -650%
  • May 6, 2026Earnings: -13.43; estimate -0.4; surprise -3257.5%
  • Aug 5, 2026Earnings: -1.06; estimate -0.74254; surprise -42.75%
  • Oct 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 12, 2026Rating: Citigroup · Buy → Buy
  • Oct 13, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Oct 13, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Oct 15, 2026Rating: Stifel · Buy → Buy
  • Oct 21, 2026Rating: TD Cowen · Buy → Buy
  • Nov 3, 2026Earnings: —; estimate -0.48682; surprise —%
Signals (146)
NameDateAgo
SMA: BearishAug 3, 20263 months ago
SMA: BearishJul 27, 20263 months ago
MACD: Sell SignalJul 27, 20263 months ago
RSI: OverboughtJun 29, 20264 months ago
MACD: Buy SignalJun 22, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishApr 27, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 6, 20267 months ago
MACD: Sell SignalMar 9, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
MACD: Buy SignalJan 5, 202610 months ago
RSI: OverboughtJan 5, 202610 months ago
SMA: BullishDec 15, 202510 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 24, 202511 months ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BearishOct 20, 20251 year ago
RSI: OverboughtAug 4, 20251 year ago

Newest 20 of 146.

Financial health

Altman Z-Score

-0.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -168×
FY 2018: -17.6×FY 2019: -10.7×FY 2020: -4.3×FY 2021: -5.8×FY 2022: -4.9×FY 2023: -7.4×FY 2024: -22.4×FY 2025: -168×
FY 2018 5y median -7.4× FY 2025
P/S 7.6×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 25.3×FY 2022: 8.6×FY 2023: 6.5×FY 2024: 5.8×FY 2025: 7.6×
FY 2018 5y median 7.6× FY 2025
P/B 12.6×
FY 2018: -29.4×FY 2019: 4.3×FY 2020: 2.6×FY 2021: 4.0×FY 2022: 4.6×FY 2023: 4.9×FY 2024: 8.7×FY 2025: 12.6×
FY 2018 5y median 4.9× FY 2025
P/FCF 72.3×
FY 2018: -38.6×FY 2019: -14.2×FY 2020: -4.9×FY 2021: -3.2×FY 2022: -5.5×FY 2023: -13.3×FY 2024: 211×FY 2025: 72.3×
FY 2018 5y median -3.2× FY 2025
EV/EBITDA 232×
FY 2018: -19.4×FY 2019: -10.6×FY 2020: -3.0×FY 2021: -7.0×FY 2022: -5.2×FY 2023: -9.0×FY 2024: -42.1×FY 2025: 232×
FY 2018 5y median -7.0× FY 2025
EV/Sales 7.6×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 23.8×FY 2022: 8.2×FY 2023: 6.6×FY 2024: 6.1×FY 2025: 7.6×
FY 2018 5y median 7.6× FY 2025
FCF Yield 1.4%
FY 2018: -2.6%FY 2019: -7.0%FY 2020: -20.3%FY 2021: -31.4%FY 2022: -18.2%FY 2023: -7.5%FY 2024: 0.5%FY 2025: 1.4%
FY 2018 5y median -7.5% FY 2025

Profitability

Gross Margin 80.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 90.1%FY 2022: 83.9%FY 2023: 74.8%FY 2024: 75.8%FY 2025: 80.7%
FY 2018 5y median 80.7% FY 2025
Operating Margin -4.2%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -906.1%FY 2022: -170.3%FY 2023: -58.6%FY 2024: -26.0%FY 2025: -4.2%
FY 2018 5y median -58.6% FY 2025
Net Margin -4.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -438.9%FY 2022: -176.0%FY 2023: -87.7%FY 2024: -26.1%FY 2025: -4.5%
FY 2018 5y median -87.7% FY 2025
ROE -7.4%
FY 2018: 168.1%FY 2019: -40.3%FY 2020: -60.0%FY 2021: -69.9%FY 2022: -95.5%FY 2023: -65.7%FY 2024: -39.0%FY 2025: -7.4%
FY 2018 5y median -65.7% FY 2025
ROIC -3.5%
FY 2018: -5.9%FY 2019: -40.8%FY 2020: -46.8%FY 2021: -68.6%FY 2022: -43.3%FY 2023: -19.5%FY 2024: -16.0%FY 2025: -3.5%
FY 2018 5y median -19.5% FY 2025
ROA -2.8%
FY 2018: -33.4%FY 2019: -35.8%FY 2020: -42.9%FY 2021: -28.5%FY 2022: -38.4%FY 2023: -25.3%FY 2024: -13.1%FY 2025: -2.8%
FY 2018 5y median -25.3% FY 2025

Growth (YoY)

Revenue 54.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 302.7%FY 2023: 141.8%FY 2024: 80.8%FY 2025: 54.7%
FY 2018 FY 2025
Operating Income 74.7%
FY 2018: 0.0%FY 2019: -1777.3%FY 2020: -90.5%FY 2021: -66.3%FY 2022: 24.3%FY 2023: 16.8%FY 2024: 19.7%FY 2025: 74.7%
FY 2018 FY 2025
EPS (diluted) 74.6%
FY 2018: 0.0%FY 2019: -205.3%FY 2020: -78.6%FY 2021: 32.3%FY 2022: -45.1%FY 2023: 0.5%FY 2024: 53.8%FY 2025: 74.6%
FY 2018 FY 2025
Free Cash Flow 488.0%
FY 2018: 0.0%FY 2019: -403.5%FY 2020: -125.3%FY 2021: -70.0%FY 2022: 20.7%FY 2023: 24.4%FY 2024: 110.2%FY 2025: 488.0%
FY 2018 FY 2025

Financial Health

Current Ratio 2.7×
FY 2018: 21.2×FY 2019: 9.1×FY 2020: 12.8×FY 2021: 3.9×FY 2022: 2.9×FY 2023: 4.5×FY 2024: 3.1×FY 2025: 2.7×
FY 2018 5y median 3.1× FY 2025
Quick Ratio 2.6×
FY 2018: 21.2×FY 2019: 9.1×FY 2020: 12.8×FY 2021: 3.9×FY 2022: 2.9×FY 2023: 4.2×FY 2024: 2.9×FY 2025: 2.6×
FY 2018 5y median 2.9× FY 2025
Debt / Equity 1.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 1.0×
FY 2018 5y median 1.0× FY 2025
Net Debt / EBITDA 1.3×
FY 2018: 4.0×FY 2019: 0.2×FY 2020: 1.4×FY 2021: 0.4×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -1.9×FY 2025: 1.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -1.5×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -311×FY 2021: -9.9×FY 2022: -8.2×FY 2023: -7.2×FY 2024: -6.1×FY 2025: -1.5×
FY 2018 5y median -7.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31